STAT signalling in malignant mesothelioma: Is there a regulatory effect of microRNAs? | springermedizin.at

Springer Medizin Österreich

nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.04.2011 | Original report

STAT signalling in malignant mesothelioma: Is there a regulatory effect of microRNAs?

verfasst von: L. Arzt, H. Kothmaier, F. Quehenberger, I. Halbwedl, H. H. Popper

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Mitomycin C in combination with vinorelbine or cisplatin and erythropoietin in pretreated patients with in field relapse after radiation therapy of non-small cell lung cancer: a phase II trial of the AIO

Nächster Artikel Comorbidity – an important domain in elderly cancer patients' assessment

Titel: STAT signalling in malignant mesothelioma: Is there a regulatory effect of microRNAs?
verfasst von: L. Arzt
H. Kothmaier
F. Quehenberger
I. Halbwedl
H. H. Popper
Publikationsdatum: 01.04.2011
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 1/2011
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-011-0241-z

Weitere Artikel der Ausgabe 1/2011

Mitomycin C in combination with vinorelbine or cisplatin and erythropoietin in pretreated patients with in field relapse after radiation therapy of non-small cell lung cancer: a phase II trial of the AIO

Original report

Associations of serum uric acid and gamma-glutamyltransferase with cancer in the Vorarlberg Health Monitoring and Promotion Programme (VHM&PP) – a short review

Short review

Comorbidity – an important domain in elderly cancer patients' assessment

Short review

Targeted therapies in advanced non-small cell lung cancer: success or failure?

Short Review

SCLC – The forgotten entity

Short Review

Large cell carcinoma of the lung – a vanishing entity?

Short review